Trevena's Grant

Trevena raised a round of funding on August 18, 2011. Investors include National Institutes of Health.

Trevena is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G protein coupled receptor (GPCR) targeted medicines. Despite the past success of GPCR d…

Articles about Trevena's Grant: